Search results
Results from the WOW.Com Content Network
World Health Organization building from the South-East, Geneva The International Pharmacopoeia (Pharmacopoeia Internationalis, Ph. Int.) is a pharmacopoeia issued by the World Health Organization [1] as a recommendation, with the aim to provide international quality specifications for pharmaceutical substances (active ingredients and excipients) and dosage forms, [2] together with supporting ...
USP 800 (Hazardous Drugs—Handling in Healthcare Settings) is a guideline created by the United States Pharmacopeia Convention (USP), as one of their General Chapters through which the USP "sets quality standards for medicines, dietary supplements and food ingredients".
Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act).
IHS is the principal federal health care provider and health advocate for American Indian people. [1] The IHS provides health care in 37 states to approximately 2.2 million out of 3.7 million American Indians and Alaska Natives (AI/AN). [2] As of April 2017, the IHS consisted of 26 hospitals, 59 health centers, and 32 health stations.
Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare which sets standards for all drugs that are manufactured, sold and consumed in India. [3]
The PDR material contained includes: . Comprehensive indexing (four sections) by Manufacturer; Products (by company's or trademarked drug name) Category index (for example, "antibiotics")
IPSG.1 Identify Patients Correctly; IPSG.2 Improve Effective Communication; IPSG.3 Improve the Safety of High-Alert Medications; IPSG.4 Ensure Correct-Site, Correct-Procedure, Correct-Patient Surgery
In drug development and medical device development [1] the Investigator's Brochure (IB) is a comprehensive document summarizing the body of information about an investigational product ("IP" or "study drug") obtained during a drug trial.